Atjaunināt sīkdatņu piekrišanu

E-grāmata: 3D & 4D Printing Methods for Pharmaceutical Manufacturing and Personalised Drug Delivery: Opportunities and Challenges

  • Formāts - EPUB+DRM
  • Cena: 71,37 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

New materials and manufacturing techniques are emerging with potential to address the challenges associated with the manufacture of pharmaceutical systems that will teach new tricks to old drugs. 3D printing (3DP) is a technique that can used for the manufacturing of dosage forms, and especially targeting paediatric and geriatric formulations, as permits the fabrication of high degrees of complexity with great reproducibility, in a fast and cost-effective fashion, and offers a new paradigm for the direct manufacture of personalised dosage forms. The book is covering the basics behind each additive manufacturing (AM) method, current applications in pharmaceutics for each 3DP method, and case studies (examples) from a teaching perspective, targeting undergraduate (UG) and postgraduate (PG) students. A unique to this book is the integration of studies based upon the use of different AM technologies, which designed to reinforce importance printing parameters and material considerations. The book includes case studies or multiple-choice questions (MCQs), which allow application of the content in a flipped-classroom.


3D and 4D printing in digital healthcare.- 3D Printing for Novel Dosage
Form Design.- 3D Printing and regulatory considerations.- Printability of
Pharmaceutical Polymers: Issues & Solutions.- Quality by Design (QbD)
approach for individualized products based on additive manufacturing,- 
Material Properties and Selections for Additive Manufacturing (AM).-
Preformulation of 3D printable pharmaceutical dosage forms.- Vat
photopolymerization Methods for Drug Delivery Applications.- Extrusion-based
3D printing methods for oral solid dosage forms.- Binder Jetting 3D Printing
in Pharmaceutical Manufacturing.- Powder bed fusion 3D printing in drug
delivery.- Bioprinting in Personalised Medications.- Shape memory materials
and 4D printing in pharmaceutics.- Characterisation methods of final printed
products.
Dimitrios Lamprou (Ph.D. MBA) is a Full Professor (Chair) of Biofabrication and Advanced Manufacturing at Queens University Belfast. Dimitrios, has been recognised as world leader in 3D Printing, with PubMed-based algorithms placed him currently in the top 0.087% of scholars in the world writing about 3D Printing in the last 10 years. He is currently the author of over 150 peer-reviewed publications and of over 350 conference abstracts, and has over 150 Oral Talks in institutions and conferences across the world. His research and academic leadership have recognised in a range of awards, including the Royal Pharmaceutical Society of Great Britain Science Award and the Scottish Universities Life Sciences Alliance Leaders Scheme Award.